• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种改进的、与检测平台无关的绝对单样本乳腺癌亚型分类器。

An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier.

作者信息

Seo Mi-Kyoung, Paik Soonmyung, Kim Sangwoo

机构信息

Department of Biomedical Systems Informatics, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Korea.

Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul 03722, Korea.

出版信息

Cancers (Basel). 2020 Nov 25;12(12):3506. doi: 10.3390/cancers12123506.

DOI:10.3390/cancers12123506
PMID:33255759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7761033/
Abstract

While intrinsic molecular subtypes provide important biological classification of breast cancer, the subtype assignment of individuals is influenced by assay technology and study cohort composition. We sought to develop a platform-independent absolute single-sample subtype classifier based on a minimal number of genes. Pairwise ratios for subtype-specific differentially expressed genes from un-normalized expression data from 432 breast cancer (BC) samples of The Cancer Genome Atlas (TCGA) were used as inputs for machine learning. The subtype classifier with the fewest number of genes and maximal classification power was selected during cross-validation. The final model was evaluated on 5816 samples from 10 independent studies profiled with four different assay platforms. Upon cross-validation within the TCGA cohort, a random forest classifier (MiniABS) with 11 genes achieved the best accuracy of 88.2%. Applying MiniABS to five validation sets of RNA-seq and microarray data showed an average accuracy of 85.15% (vs. 77.72% for Absolute Intrinsic Molecular Subtype (AIMS)). Only MiniABS could be applied to five low-throughput datasets, showing an average accuracy of 87.93%. The MiniABS can absolutely subtype BC using the raw expression levels of only 11 genes, regardless of assay platform, with higher accuracy than existing methods.

摘要

虽然内在分子亚型为乳腺癌提供了重要的生物学分类,但个体的亚型分类受检测技术和研究队列组成的影响。我们试图基于最少数量的基因开发一种与平台无关的绝对单样本亚型分类器。来自癌症基因组图谱(TCGA)的432例乳腺癌(BC)样本的未标准化表达数据中,亚型特异性差异表达基因的成对比率被用作机器学习的输入。在交叉验证过程中,选择了基因数量最少且分类能力最强的亚型分类器。最终模型在来自10项独立研究的5816个样本上进行了评估,这些样本使用四种不同的检测平台进行了分析。在TCGA队列中进行交叉验证时,一个包含11个基因的随机森林分类器(MiniABS)达到了88.2%的最佳准确率。将MiniABS应用于RNA测序和微阵列数据的五个验证集,平均准确率为85.15%(相比绝对内在分子亚型(AIMS)的77.72%)。只有MiniABS可以应用于五个低通量数据集,平均准确率为87.93%。MiniABS仅使用11个基因的原始表达水平就能对BC进行绝对亚型分类,无论检测平台如何,其准确率都高于现有方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/6b1feca601bb/cancers-12-03506-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/2a6109d783de/cancers-12-03506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/1058d7b28778/cancers-12-03506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/183f5a25f317/cancers-12-03506-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/6b1feca601bb/cancers-12-03506-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/2a6109d783de/cancers-12-03506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/1058d7b28778/cancers-12-03506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/183f5a25f317/cancers-12-03506-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f181/7761033/6b1feca601bb/cancers-12-03506-g004.jpg

相似文献

1
An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier.一种改进的、与检测平台无关的绝对单样本乳腺癌亚型分类器。
Cancers (Basel). 2020 Nov 25;12(12):3506. doi: 10.3390/cancers12123506.
2
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.使用配对的新鲜冷冻组织与福尔马林固定石蜡包埋组织的RNA对三阴性乳腺癌分子亚型进行比较。
BMC Cancer. 2017 Apr 4;17(1):241. doi: 10.1186/s12885-017-3237-1.
3
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.CUP-AI-Dx:一种使用 RNA 基因表达数据和人工智能推断癌症组织来源和分子亚型的工具。
EBioMedicine. 2020 Nov;61:103030. doi: 10.1016/j.ebiom.2020.103030. Epub 2020 Oct 9.
4
Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.用于预测高级别浆液性卵巢癌分子亚型的平台无关分类系统
JCO Clin Cancer Inform. 2019 Apr;3:1-9. doi: 10.1200/CCI.18.00096.
5
Machine learning for RNA sequencing-based intrinsic subtyping of breast cancer.基于 RNA 测序的乳腺癌内在分型的机器学习。
Sci Rep. 2020 Aug 21;10(1):14071. doi: 10.1038/s41598-020-70832-2.
6
Absolute assignment of breast cancer intrinsic molecular subtype.乳腺癌内在分子亚型的绝对分类。
J Natl Cancer Inst. 2014 Dec 4;107(1):357. doi: 10.1093/jnci/dju357. Print 2015 Jan.
7
Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.通过基因表达荟萃分析研究乳腺癌亚型相关的基因和通路。
Gene. 2022 May 5;821:146328. doi: 10.1016/j.gene.2022.146328. Epub 2022 Feb 16.
8
Prediction of breast cancer metastasis by gene expression profiles: a comparison of metagenes and single genes.通过基因表达谱预测乳腺癌转移:元基因与单基因的比较
Cancer Inform. 2012;11:193-217. doi: 10.4137/CIN.S10375. Epub 2012 Dec 10.
9
A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.一种用于预测三阴性乳腺癌免疫亚型的机器学习模型。
Front Immunol. 2021 Sep 17;12:749459. doi: 10.3389/fimmu.2021.749459. eCollection 2021.
10
Development and validation of a NanoString BASE47 bladder cancer gene classifier.开发和验证一种用于膀胱癌的 NanoString BASE47 基因分类器。
PLoS One. 2020 Dec 17;15(12):e0243935. doi: 10.1371/journal.pone.0243935. eCollection 2020.

引用本文的文献

1
The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtype.乳腺癌分类器优化了分子乳腺癌分类,以界定HER2低表达亚型。
NPJ Breast Cancer. 2025 Feb 20;11(1):19. doi: 10.1038/s41523-025-00723-0.
2
Building flexible and robust analysis frameworks for molecular subtyping of cancers.构建灵活稳健的癌症分子亚型分析框架。
Mol Oncol. 2024 Mar;18(3):606-619. doi: 10.1002/1878-0261.13580. Epub 2024 Jan 7.
3
A Simple Method for Robust and Accurate Intrinsic Subtyping of Breast Cancer.

本文引用的文献

1
Cep55 overexpression promotes genomic instability and tumorigenesis in mice.CEP55 过表达促进小鼠的基因组不稳定性和肿瘤发生。
Commun Biol. 2020 Oct 21;3(1):593. doi: 10.1038/s42003-020-01304-6.
2
Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network-Breast Initiative.基于RNA测序的分类器对五种传统乳腺癌生物标志物预测的临床价值:来自基于人群的多中心瑞典癌症基因组分析网络-乳腺癌倡议的报告
JCO Precis Oncol. 2018 Mar 9;2. doi: 10.1200/PO.17.00135. eCollection 2018.
3
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
一种用于乳腺癌稳健且准确的内在亚型分型的简单方法。
Cancer Inform. 2023 Mar 25;22:11769351231159893. doi: 10.1177/11769351231159893. eCollection 2023.
4
Value of genomics- and radiomics-based machine learning models in the identification of breast cancer molecular subtypes: a systematic review and meta-analysis.基于基因组学和放射组学的机器学习模型在乳腺癌分子亚型识别中的价值:一项系统综述和荟萃分析。
Ann Transl Med. 2022 Dec;10(24):1394. doi: 10.21037/atm-22-5986.
5
Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis.基于荟萃分析的肿瘤微环境感知的结直肠癌单转录组微卫星不稳定性预测。
Sci Rep. 2022 Apr 15;12(1):6283. doi: 10.1038/s41598-022-10182-3.
21 基因复发评分在 26 到 100 之间的早期乳腺癌患者接受辅助化疗加内分泌治疗的临床结局:TAILORx 随机临床试验的二次分析。
JAMA Oncol. 2020 Mar 1;6(3):367-374. doi: 10.1001/jamaoncol.2019.4794.
4
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.早期乳腺癌:ESMO 诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 Aug 1;30(8):1194-1220. doi: 10.1093/annonc/mdz173.
5
Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at .PAM50 表达的重参数化可识别新的乳腺肿瘤维度,并导致在. 发现全基因组显著的乳腺癌基因座。
Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):644-652. doi: 10.1158/1055-9965.EPI-17-0887. Epub 2018 Apr 12.
6
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.PAM50 和复发风险评分在长期随访的早期乳腺癌患者中的预后价值。
Breast Cancer Res. 2017 Nov 14;19(1):120. doi: 10.1186/s13058-017-0911-9.
7
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.降阶梯和升阶梯治疗早期乳腺癌:2017 年圣加仑国际早期乳腺癌专家共识会议关于早期乳腺癌的主要治疗。
Ann Oncol. 2017 Aug 1;28(8):1700-1712. doi: 10.1093/annonc/mdx308.
8
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.原发性和转移性乳腺癌的内在亚型及基因表达谱
Cancer Res. 2017 May 1;77(9):2213-2221. doi: 10.1158/0008-5472.CAN-16-2717. Epub 2017 Mar 1.
9
Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.乳腺癌脑转移中的内在亚型转换以及获得性 ERBB2/HER2 扩增和突变。
JAMA Oncol. 2017 May 1;3(5):666-671. doi: 10.1001/jamaoncol.2016.5630.
10
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.70 基因特征作为早期乳腺癌治疗决策的辅助手段。
N Engl J Med. 2016 Aug 25;375(8):717-29. doi: 10.1056/NEJMoa1602253.